LadRx Competitors and Similar CompaniesClear all
LadRx's competitors and similar companies include ImmunoMet, Fennec Pharma, Rasna Therapeutics and Urogen Pharma.
 LadRx LadRx Corporation (formerly known as CytRx Corporation) is a biopharmaceutical company focused on discovering, developing and commercializing new therapeutics to treat patients with cancer. |  ImmunoMet ImmunoMet is a clinical-stage biotechnological company that specializes in tumor metabolism and immuno-metabolism. |  Fennec Pharma Fennec Pharmaceuticals is a biotechnology company focused on the development of Sodium Thiosulfate for the prevention of ototoxicity from cisplatin in pediatric patients. |  Rasna Therapeutics Rasna Therapeutics focusses on development therapeutics to address the high unmet need that exists for AML and other forms of leukemia. | ||
Founding Date | Founding Date 1985 | Founding Date 2015 | Founding Date 1996 | Founding Date 2013 | Founding Date 2004 |
Type | Type Public | Type Private | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Los Angeles, US HQ | Locations Houston, US HQ | Locations US HQ | Locations New York, US HQ Greater London, GB Doylestown, US | Locations New York, US HQ Tel Aviv Yafo, IL Princeton, US |
Employees | Employees 385% decrease | Employees 814% increase | Employees 433% increase | Employees N/A | Employees 194362% increase |
Valuation ($) | Valuation ($) 901.1 k | Valuation ($) N/A | Valuation ($) 129.4 m | Valuation ($) 3.1 m | Valuation ($) 515.9 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $44.6m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $109.8m (FY, 2025) |
Net income | Net income ($1.6m) (FY, 2024) | Net income N/A | Net income ($9.7m) (FY, 2025) | Net income ($4.4m) (FY, 2023) | Net income ($153.5m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
ImmunoMet
HQ
Houston, US
Employees
8↑ 14% increase
ImmunoMet is a clinical-stage biotechnological company that specializes in tumor metabolism and immuno-metabolism.
View companyFennec Pharma
HQ
US
Employees
4↑ 33% increase
Fennec Pharmaceuticals is a biotechnology company focused on the development of Sodium Thiosulfate for the prevention of ototoxicity from cisplatin in pediatric patients.
View companyRasna Therapeutics
HQ
New York, US
Rasna Therapeutics focusses on development therapeutics to address the high unmet need that exists for AML and other forms of leukemia.
View company
Urogen Pharma
HQ
New York, US
Employees
194
UroGen Pharma is a clinical-stage biopharmaceutical company.
View company